Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Joseph Kissil Named Scripps Florida 2014 Outstanding Mentor

October 27, 2014 – 12:00 am | Edit Post

The Outstanding Mentor Award celebrates principal investigators who demonstrate accessibility, supportiveness, propensity for providing constructive criticism and concern for mentees’ careers.

Alzheimer’s, Down syndrome link found

October 26, 2014 – 8:50 pm | Edit Post

Sanford-Burnham research points to possible therapies for both conditions.

Alzheimer’s, Down syndrome link found

October 26, 2014 – 8:50 pm | Edit Post

Sanford-Burnham research points to possible therapies for both conditions.

To quarantine or not?

October 26, 2014 – 7:52 pm | Edit Post

Nation’s top infectious disease expert says automatic quarantines don’t make medical sense.

To quarantine or not?

October 26, 2014 – 7:52 pm | Edit Post

Nation’s top infectious disease expert says automatic quarantines don’t make medical sense.

CDC Supports Recruitment For MediciNova, Inc.’s Clinical Trial Of MN-166 (Ibudilast) In ALS

October 24, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the U.S. CDC’s National ALS Registry Research Committee has voted…

Edwards Lifesciences Corporation Reports Third Quarter Results

October 24, 2014 – 5:00 am | Edit Post

IRVINE, Calif., Oct. 23, 2014 /PRNewswire/ –Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended September 30, 2014 of

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2015

October 24, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 23, 2014 /PRNewswire/ –ResMed Inc. (NYSE: RMD) today announced results for its quarter ended September 30, 2014. Revenue for the quarter was $380.4 million, a 6 percent increase compared to the quarter ended September…

La Jolla Pharmaceutical Company Announces Data Presentation At The American Society of Nephrology Kidney Week

October 24, 2014 – 5:00 am | Edit Post

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that an abstract of the results for the Companys Phase 2 clinical trial of GCS-100 in chronic kidney disease (CKD) has been selected by the American Society…

BiCOM Announces 2014 Elected Official Of The Year

October 24, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 23, 2014 /PRNewswire/ — Biocom, the association for the Southern California life science community, today announced that Congressman Scott Peters (D-52) will be honored as Biocom’s 2014 Elected Official of the Year at the Biocom Celebration…